Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück zu finanzen.net geht es hier.
SMI 10’794 3.3%  SPI 13’946 3.4%  Dow 31’501 2.7%  DAX 13’118 1.6%  Euro 1.0116 0.0%  EStoxx50 3’533 2.8%  Gold 1’827 0.2%  Bitcoin 20’448 0.9%  Dollar 0.9593 -0.2%  Öl 113.2 3.1% 
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
24.05.2022 13:51:32

Insulet's stock is up on Bloomberg report that it may be acquired by Dexcom

Shares of Insulet Corp. gained 9.9% in premarket trading on Tuesday, the day after Bloomberg reported that the company is in talks to be acquired by Dexcom Inc. , citing anonymous sources. Dexcom's stock was down 7.1% before the market opened on Tuesday. A tie-up between the companies would create a major player in the diabetes sector. Dexcom manufactures continuous glucose monitoring systems, while Insulet makes a disposable insulin delivery system. Insulet CEO Shacey Petrovic announced earlier this month that she's stepping down June 1 for family reasons. Insulet's stock is down 23.7% this year, while the broader S&P 500 has slid 18.1%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Weiter zum vollständigen Artikel bei "Market Watch"

BITCOIN KURSZIEL 100'000 US-DOLLAR? WELCHER COIN KÖNNTE DER NÄCHSTE VERDOPPLER SEIN?

Informieren Sie sich aus erster Hand über Nachrichten, die Krypto-Kurse bewegen. Abonnieren Sie jetzt kostenlos unseren neuen Krypto-Newsletter!